ClinicalTrials.gov
public full text
Public Domain
Cabergoline Effect on Blood Sugar in Type 2 Diabetics
Diabetic patients with poorly control blood sugar are prescribed cabergoline for 1 months and their blood glucose is evaluated.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effect of Cabergoline on Weight and Glucose Tolerance#851082
- Effects of Modulators of Gluconeogenesis, Glycogenolysis and Glucokinase Activity#1150407
- Effect of Acarbose and Mixture of Pioglitazone and Metformin in Patients With Type 2 Diabetes#146431
- Double Blind Randomized Trial to Compare Gurmar (Gymnema Sylvestre) With Metformin in Type 2 Diabetes#303711
- A Clinical Study of Insulin Degludec Injection in Subjects With Type 2 Diabetes#860188
Record · ID 1292768
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive